PDCD1 and neoplasm: Binding of immune checkpoint receptors, such as programmed cell death ligand-1 (PD-L1) on cancer cells to programmed cell death protein-1 (PD-1) on T cells, inhibits T cell activation and induces a hypofunctional, “exhausted” T cell state that fails to contain tumor progression.